Related Experiment Videos
Percutaneous transluminal coronary angioplasty in left main stem coronary stenosis: a five-year appraisal
Insights
Percutaneous transluminal coronary angioplasty offers a viable primary treatment for select left main stem coronary stenosis cases, achieving high success rates. While coronary artery bypass grafting remains standard, angioplasty provides a non-operative option for specific patients.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Medicine
Background:
- Left main stem coronary stenosis is typically managed with coronary artery bypass grafting.
- Percutaneous transluminal coronary angioplasty (PTCA) has improved outcomes in other coronary artery diseases.
- The application of PTCA for left main stem stenosis has been limited and debated.
Purpose of the Study:
- To evaluate the efficacy and safety of PTCA as a primary treatment for left main stem coronary stenosis.
- To identify patient subgroups who may benefit from PTCA over traditional surgery.
Main Methods:
- A retrospective analysis of 20 PTCA procedures in 19 patients with left main stem coronary stenosis.
- Assessment of primary success rates, need for emergency surgery, and long-term outcomes.
Main Results:
- A 95% primary success rate was observed for PTCA in left main stem stenosis.
- Only one patient (5%) required emergency surgery, with no deaths directly attributed to PTCA.
- After a mean follow-up of 41 months, 63% of patients remained free from further intervention.
Conclusions:
- PTCA can be a safe and effective primary therapy for specific cases of left main stem coronary stenosis.
- Coronary artery bypass grafting remains the gold standard, but PTCA is a valuable alternative in selected patients.
- This study highlights exceptions where PTCA may be preferred over surgical revascularization for left main stem disease.
Abstract:
Left main stem coronary stenosis is now uniformly treated with coronary artery bypass grafting. The advent of percutaneous transluminal coronary angioplasty has permitted a non-operative improvement in myocardial blood flow in many cases of single- and multi-vessel coronary atherosclerosis. The use of percutaneous transluminal coronary angioplasty in left main stem coronary stenosis has been sporadic and controversial. Twenty percutaneous transluminal coronary angioplasties were attempted in 19 patients as the treatment of choice for left main stem coronary stenosis in the past 66 months. The primary success rate was 95% (19/20 patients). The emergency surgery was performed only once (5%), and no death occurred secondary to percutaneous transluminal coronary angioplasty itself. In the follow-up (mean 41 months) period, 12 patients (63%) remained in satisfactory condition with no further need for surgical intervention. Seven patients (37%) ultimately required coronary artery bypass grafting. Although coronary artery bypass grafting will remain the fundamental treatment for left main stem coronary stenosis, this series delineates those anatomic and clinical exceptions wherein percutaneous transluminal coronary angioplasty may be utilized as the primary therapy for left main stem coronary stenosis.